Totally agree, PTX100 is first to market, once the money pours in from the sales, they could possibly consider bringing back PTX 200 at some point, however I think even without it our pipeline is pretty darn impressive
As for a licensing deal, I wouldn’t be surprised if CEO James could land one for us.
I have heard through a top shareholder friend,that James is seriously satisfied
to have landed the CEO position and is absolutely motivated to push Prescient Theraputics
to great heights.
All we need now is some glowing data from Phase 2a to get some attention on our company
So many companies like Prescient fly under the radar for years until one day,bang
everyone is talking about them, look at what happened just recently with ATX
I had never even heard of them before they achieved a second complete response
in pancreatic cancer.
our time in the sun will come later this year I think.
Add to My Watchlist
What is My Watchlist?
